Naftidrofuryl (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C04AX21
CAS registry number (Chemical Abstracts Service)
0031329-57-4
Chemical Formula
C24-H33-N-O3
Molecular Weight
384
Therapeutic Category
Peripheral vasodilator
Chemical Name
2-Furanpropanoic acid, tetrahydro-α-(1-naphtalenylmetyl)-, 2-(dietylamino)etyl ester
Foreign Names
- Naftidrofurylum (Latin)
- Naftidrofuryl (German)
- Naftidrofuryl (French)
- Naftidrofurilo (Spanish)
Generic Names
- Naftidrofurile (OS: DCIT)
- Naftidrofuryl (OS: BAN, DCF)
- EU-1806 (IS)
- LS 121 (IS)
- Nafronyl (IS)
- Nafronyl Oxalate (OS: USAN)
- Naftidrofuryl Oxalate (OS: BANM, JAN)
- Naftidrofuryl (oxalate acide de) (PH: Ph. Eur. 9)
- Naftidrofuryl hydrogen oxalate (PH: Ph. Eur. 9)
- Naftidrofuryl hydrogenoxalat (PH: Ph. Eur. 9)
- Naftidrofuryl Oxalate (PH: BP 2018)
- Naftidrofuryli hydrogenooxalas (PH: Ph. Eur. 9)
Brand Names
- Cerebromap
Apex, Egypt - Clarantin
Medochemie, Tunisia - Naftilong 200 mg retard
Hexal, Hungary - Naftor
ACT Pharma, Tunisia - Praxilene
Lipha Sante, Lebanon; Merck, Egypt; Merck Santé, Tunisia - Cirpril
Kwang Dong, South Korea - Clarantin
Medochemie, Cyprus - Diactane
Menarini, France - Drosunal
Balkanpharma-Dupnitsa, Bulgaria - Dusodril
Merck Sante, Romania; Merck Serono, Germany - Dusodril 100mg
Famar L'Aigle, Bulgaria - Dusodril 200mg
Famar Lyon, Bulgaria; Merck S.L., Bulgaria - Dusodril forte
Merck Serono, Germany - Dusodril retard
Merck Serono, Germany - Dusodril retard 100 mg
Merck, Austria - Dusodril retard 200 mg
Merck, Austria - Dusopharm
Unipharm, Bulgaria - Enelbin
Zentiva, Latvia - Enelbin retard
STADA, Slovakia; Zentiva, Czech Republic; Zentiva, Estonia - Frilix
Pharos, Indonesia - Iridus
Sanofi-Aventis, Mexico; Sanofi-Aventis, Venezuela - Nafly
Samil, South Korea - Nafoxal
Sandoz, Indonesia - Nafril
Hanall Biopharma, South Korea - Nafti-CT
AbZ-Pharma, Germany - Naftidrofuryl
Actavis UK, United Kingdom - Naftidrofuryl Biogaran
Biogaran, France - Naftidrofuryl EG
EG Labo, France - Naftidrofuryl Mylan
Mylan, France - Naftidrofuryl Ranbaxy
Ranbaxy, France - Naftidrofuryl Teva
Teva Santé, France - Naftidrofuryl Zentiva
Sanofi-Aventis, France - Naftilong
Hexal, Germany - Naftilong 100 mg retard
Hexal, Hungary - Naftilux
Thérabel Lucien, France - Nafti-ratiopharm
ratiopharm, Germany - Praxilene
Alapis A.B.E.E., Greece; Faes, Spain; Formenti, Italy; Lipha, Kuwait; Merck, Hong Kong; Merck, Indonesia; Merck, Portugal; Merck Consumer Healthcare, Belgium; Merck Serono, France; Merck Serono, United Kingdom; Merck Serono, Ireland; Merck Merck Serono Division, Singapore - Praxilene 200mg
Merck, Switzerland; Merck, Luxembourg; Merck KGaA, Vietnam - Vascuprax
Ikapharmindo, Indonesia; Lipha, Indonesia
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.